FindTrial
Sign In

Acute Febrile Illness Surveillance

Community based Surveillance to estimate incidence and sero prevalence of acute febrile illness with focus on Dengue and Chikungunya â?? A prospective multi-centric cohort Study. - DRIVEN - 2020

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/05/053025
Enrollment
752
Registered
2023-05-22
Start date
Unknown
Completion date
Unknown
Last updated
2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Nil: Nil

Sponsors

BIRAC
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: (1) Study will be carried out in individuals above 2 Years of age. (2) Individuals currently residing and likely to stay till the end of one year in the study area. (3) Consented to participate in both sections of the study (Sero Prevalence and AFI Surveillance) and follow all procedures.

Exclusion criteria

Exclusion criteria: Ongoing fever episodes or history of AFI on or within 3 calendar days before enrolment for the cohort

Design outcomes

Primary

MeasureTime frame
Age specific attack rate Age-specific cumulative incidence of asymptomatic Dengue and Chikungunya infections Age-specific cumulative incidence of symptomatic Dengue and Chikungunya events Age Specific sero prevalence and sero incidence of neutralizing antibodies Symptomatic proportion of cases (asymptomatic fraction)Timepoint: 13 Months—

Secondary

MeasureTime frame
Incidence of Acute febrile Illnesses - Malaria, Typhoid, Leptospirosis and Scrub typhusTimepoint: 13 months—

Countries

India

Contacts

Public ContactDr Abhishek Agarwal

The INCLEN Trust International

abhishek.agarwal@inclentrust.org9582366630

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026